Article Details
Retrieved on: 2020-11-08 21:48:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... National Institute of Allergy and Infectious Diseases (NIAID) to focus on phase 3 efficacy trials for COVID-19 vaccines and <b>monoclonal antibodies</b>.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here